Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limited period of between three weeks and 30 months. T...
Spremljeno u:
Glavni autori: | , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Centro de Investigaciones y Publicaciones Farmaceuticas,
2020-06-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |